Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.

Lotze, M T; Zeh, H J; Elder, E M; Cai, Q; Pippin, B A; Rosenstein, M M; Whiteside, T L; Herberman, R

Lotze, M T; Zeh, H J; Elder, E M; Cai, Q; Pippin, B A; Rosenstein, M M; Whiteside, T L; Herberman, R.

Affiliation

Lotze MT; Department of Surgery, University of Pittsburgh Medical Center, PA 15261.

J Immunother (1991) ; 12(3): 212-7, 1992 Oct.

Article in En | MEDLINE | ID: mdl-1359903

Subject(s)

Interleukins/pharmacology; Lymphocytes, Tumor-Infiltrating/drug effects; Melanoma/immunology; Cell Division/drug effects; Drug Synergism; Genetic Therapy; Interleukin-10/pharmacology; Interleukin-12; Interleukin-2/pharmacology; Interleukin-4/pharmacology; Interleukin-7/pharmacology; Tumor Cells, Cultured/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphocytes, Tumor-Infiltrating / Interleukins / Melanoma Language: En Journal: J Immunother (1991) Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / NEOPLASIAS Year: 1992 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links